Insiders bioMérieux

Stocks

Market Closed - Euronext Paris Other stock markets 11:55:00 2026-07-15 am EDT			5-day change	1st Jan Change
71.85 ^EUR	+2.35%		+3.90%	-34.86%

Jul. 14	Biomérieux Showcases Latest Diagnostic Solutions and Innovations At ADLM 2026	CI
Jul. 10	Sadif Investment Analytics Upgrades bioMérieux to Hold Rating	MT

Mar. 15	Plair SA announced that it has received funding from bioMérieux S.A.	CI
24-06-30	Aurobac Therapeutics, founded by Boehringer Ingelheim, bioMerieux and Evotec, Names Scientific Advisory Board	CI
24-01-16	BioMérieux appoints two new members to its Executive Committee
23-06-28	BioMérieux: new Director of Clinical Operations
18-02-28	BioMérieux S.A Recommends Dividend, Payable on May 17, 2018, Announces Executive Changes	CI
17-12-15	BioMérieux Announces Management Changes	CI
16-09-02	BioMérieux S.A. Acknowledges the Appointment of Michel Baguenault as Secretary General	CI
14-05-28	BioMérieux Announces Board Changes	CI
14-04-15	Alexandre Mérieux Assumes Role of bioMérieux's Chief Executive Officer and Head of Its Management Committee	CI
14-02-05	BioMérieux SA Appoints Claire Giraut as Corporate Vice President and CFO	CI
13-07-18	BioMérieux SA Announces Management Changes	CI
13-05-21	BioMérieux SA Appoints of Nicolas Cartier as Corporate Vice President	CI